cSCCs commonly harbor dense CD3+ infiltrates, yet effective tumor control is associated with spatially accessible, proliferative CD8+ effector and tissue-resident memory populations, whereas disease progression correlates with regulatory T-cell enrichment, stromal remodeling, and cytokine-driven immune exclusion. The gene discussed is CD8A; the disease is neoplasm.